Table 3 Antidiabetic medication in diabetic participants with normoalbuminuria, microalbuminuria, and macroalbuminuria
Medication | Normoalbuminuric | Microalbuminuric | Macroalbuminuric | P |
|---|---|---|---|---|
N | n = 371 | n = 158 | n = 52 | |
Antidiabetic treatment | ||||
Oral antidiabetic medication only (%) | 42.1 | 30.4 | 30.8 | 0.0062 |
Insulin only (%) | 26.7 | 38.6 | 36.5 | |
Oral antidiabetic medication in combination with insulin (%) | 20.2 | 26.0 | 30.8 | |
No antidiabetic drug | 11.1 | 5.1 | 1.9 | |
Antihypertensive/Cardiovascular medication | ||||
Beta blockers (%) | 40.2 | 38.6 | 57.7 | 0.0401 |
ACE inhibitors (%) | 44.7 | 46.2 | 48.1 | 0.8801 |
Diuretic use (%) | 37.5 | 50.0 | 51.9 | 0.0092 |
AT 1 blockers (%) | 8.9 | 9.5 | 15.4 | 0.3311 |
Calcium channels blockers (%) | 17.8 | 22.8 | 23.1 | 0.3353 |
Lipid lowering drugs (%) | 37.2 | 36.7 | 42.3 | 0.7523 |
Antiplatelet drugs (%) | 44.7 | 45.6 | 44.2 | 0.9794 |